gene.com
Genentech: Our Medicines
http://www.gene.com/patients/medicines
Genentech has multiple products on the market for serious or life-threatening medical conditions. Somatropin (rDNA origin) for injection). You Might Also Be Interested In. A guide for dealing with used sharps responsibly. Access to Investigational Medicines. We're committed to a fair and impartial evaluation of each request for access to our investigational medicines. Find Open Clinical Trials. Search clinicaltrials.gov to find out if a trial exists for a specific medicine for a particular disease.
oncoprescribe.com
OncoPrescribe - Write The Perfect Prescription
http://oncoprescribe.com/blog
The latest from OncoPrescribe and the Oncology World. KEYTRUDA – A promising Immunotherapy for Metastatic Melanoma. September 13th, 2014. Granted accelerated approval to KEYTRUDA. Pembrolizumab), a humanized anti PD-1 antibody. For the treatment of patients with advanced Metastatic Melanoma. Who have disease progression following YERVOY. Posted in Malignant Melanoma. ZYDELIG – A New Treatment Option for Non-Hodgkin Lymphoma. August 24th, 2014. Posted in Non Hodgkins Lymphoma. KADCYLA beneficial for patie...
owlspecialty.com
Med List
http://www.owlspecialty.com/index.php/specialty-medications
Written by Administrator on 16 January 2015. Owl Specialty Pharmacy provides many specialty disease medications. Here is a list of popular medications that are offered to our patients. List of Common Specialty Medications:. Fentanyl) nasal spray CII. Leuprolide acetate for depot suspension). Skin Cancer / Melanoma. EPCLUSA (sofosbuvir and velpatasvir). Ombitasvir, paritaprevir, and ritonavir). Ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets). Teriparatide [rDNA origin] injection).
simslandyacht.blogspot.com
Sims Land Yacht Stories: February 2014
http://simslandyacht.blogspot.com/2014_02_01_archive.html
Sims Land Yacht Stories. Life is all about "the stories". This is ours from our RV somewhere in the U.S. Wednesday, February 26, 2014. Long Day in Corpus. Connie had MRI's on her brain and spine this morning. We will get those results back on Monday when we meet with the Oncologist. Dropped her off at 8:30, picked her up at 11:30a. Will blog again with the results from Monday. Thursday, February 6, 2014. Connie's changing treatments as of last Monday (2/3/14), going to a TDM1 treatment. Which we hope wil...
epatientgr.wordpress.com
Πόσο μπορεί να κοστίζει ένα νέο φάρμακο; How much can a new medicine cost? | EpatientGR's Blog
https://epatientgr.wordpress.com/2014/11/05/πόσο-μπορεί-να-κοστίζει-ένα-νέο-φάρμακ
Ποιά είναι η epatientGR; Αbout epatientGR. Υγεία και Κοινωνικά Δίκτυα-Healthcare and Social Networks. Πόσο μπορεί να κοστίζει ένα νέο φάρμακο; How much can a new medicine cost? On Νοεμβρίου 5, 2014 · Σχολιάστε. English Translation at the end of the text in Greek. Τιμή είναι αυτό που πληρώνεις, αξία είναι αυτό που παίρνεις-. H διεθνής ογκολογική κοινότητα παρακολουθεί με ανησυχία τις συνεχώς αυξανόμενες τιμές των νέων φαρμάκων. Οι νέες πολλά υποσχόμενες θεραπείες της ακριβούς. Για τη φαρμακοβιομηχανία, η ...
immunogen.com
Immunogen | Our ADC Technology | Kadcyla
http://www.immunogen.com/kadcyla
What is an ADC? What is an ADC? Ado-trastuzumab emtansine, formerly T-DM1). In the US, Kadcyla is marketed by Genentech, a member of the Roche Group. US healthcare providers and patients should refer to Genentech’s Kadcyla website. For information on this product. Kadcyla consists of our DM1 cell-killing agent attached to Roche’s HER2-targeting antibody, trastuzumab, using our SMCC linker ( emtansine is DM1 attached using SMCC). New England Journal of Medicine. Last updated: March 30, 2015.
